73D-28254-60696 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-10-02
Registered in v-safe
2021-10-02
Dose 1 — Pfizer-BioNTech
2021-10-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Redness · Headache · Be unable to do your normal daily activities

Adult check-in
2021-10-06
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-10-16
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-10-23
Dose 2 — Pfizer-BioNTech
2022-01-04
Survey response — 3 months, dose 1
MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Covid-19

MedDRA releases: 2024-11 · check-in free text available
2022-04-04
Survey response — 6 months, dose 1
MedDRA: Pregnancy — Feeling: Good

Free text: Pregnant

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-10-02	Pfizer-BioNTech	No
2	2021-10-23	Pfizer-BioNTech	No

Free text

Release 10 — 3 months, dose 1

2022-01-04

Symptoms: Covid-19

Release 11 — 6 months, dose 1

2022-04-04

Symptoms: Pregnant

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release